Cohen L, Holzman R S, Valentine F T, Lawrence H S
J Exp Med. 1976 Apr 1;143(4):791-804. doi: 10.1084/jem.143.4.791.
After our initial report tha leukocyte dialysates containing transfer factor augment the thymidine incorporation of antigen-stimulated lymphocytes, we have adapted the system to microleukocyte cultures. This modification permits both (a) the simultaneous assay of a single dialysate on the cells of multiple individuals, and (b) the assay of multiple dialysates on the cells of a single individual. The data thus secured, demonstrate that dialysates from both skin-test-positive and -negative donors produced similar degrees of augmentation whether the data are expressed as an arithmetic difference or as a ratio. When expressed as an arithmetic difference, the amount of augmentation is increased in proportion to the level of thymidine incorporation of the assay cells when they were stimulated by antigen alone. When expressed as a ratio, however, the degree of augmentation is independent of the response of the assay cells. An analysis of the ability of dialysates to engage previously uncommitted lymphocytes and thus to augment thymidine incorporation, revealed that precommitted cells were required. In these experiments, antigen-reactive cells were deleted from populations of peripheral blood lymphocytes by incubation with purified protein derivative of tuberculin, diphtheria toxoid, or streptokinase-streptodornase in the presence of [3H]thymidine of high specific activity. This deletion depressed or abolished the effect of dialysate on the residual population when it was recultured with the same antigen, but the effect on the response of the remaining lymphocytes to other antigens was unaltered. In this study, leukocyte dialysate appeared to augment nonspecifically the thymidine incorporation of an antigen-specific precommitted clone of lymphocytes. The relationship of these adjuvant effects on peripheral blood lymphocytes in vitro to the specific and nonspecific activities of transfer factor in vivo remains to be elucidated.
在我们最初报道含有转移因子的白细胞透析液可增强抗原刺激淋巴细胞的胸腺嘧啶核苷掺入后,我们已将该系统应用于微量白细胞培养。这种改进使得:(a) 能够同时对多个个体的细胞进行单一透析液的检测;(b) 能够对单个个体的细胞进行多种透析液的检测。由此获得的数据表明,无论数据是以算术差值还是以比值表示,皮肤试验阳性和阴性供体的透析液产生的增强程度相似。以算术差值表示时,当检测细胞仅受抗原刺激时,增强量与胸腺嘧啶核苷掺入水平成比例增加。然而,以比值表示时,增强程度与检测细胞的反应无关。对透析液使先前未定向淋巴细胞定向并因此增强胸腺嘧啶核苷掺入能力的分析表明,需要预先定向的细胞。在这些实验中,通过在高比活度的[3H]胸腺嘧啶核苷存在下与结核菌素纯蛋白衍生物、白喉类毒素或链激酶 - 链道酶一起孵育,从外周血淋巴细胞群体中删除抗原反应性细胞。当用相同抗原重新培养时,这种删除降低或消除了透析液对剩余群体的作用,但对其余淋巴细胞对其他抗原反应的作用未改变。在本研究中,白细胞透析液似乎非特异性地增强了淋巴细胞抗原特异性预先定向克隆的胸腺嘧啶核苷掺入。这些体外对外周血淋巴细胞的佐剂作用与体内转移因子的特异性和非特异性活性之间的关系仍有待阐明。